Search
for
Sort by
Research 31–60 of 74
- 17β-Estradiol Increases APE1/Ref-1 Secretion in Vascular Endothelial Cells and Ovariectomized Mice: Involvement of Calcium-Dependent Exosome Pathway
- Evidence for supplemental treatments in androgenetic alopecia.
- Mechanism of action of minoxidil in the treatment of androgenetic alopecia is likely mediated by mitochondrial adenosine triphosphate synthase-induced stem cell differentiation.
- Nutraceuticals for Androgenetic Alopecia.
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- Comparative study between the efficacy of topical sildenafil and topical minoxidil in the treatment of male androgenic alopecia
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- PROTACs: A novel strategy for cancer drug discovery and development
- Autotaxin–lysophosphatidic acid– LPA <sub>3</sub> signaling at the embryo‐epithelial boundary controls decidualization pathways
- Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia
- Female pattern alopecia: current perspectives
- Bee pollen and honey for the alleviation of hot flushes and other menopausal symptoms in breast cancer patients
- Female Pattern Hair Loss
- Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
- Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings
- Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
- Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Pubertal hormones increase hippocampal expression of α4βδ GABAA receptors
- Efficacy of finasteride for treating patients with androgenetic alopecia who are pileous in other areas: A pilot study in Japan
- Does topical minoxidil at concentrations higher than 5% provide additional clinical benefit?
- Cancer-Related Alopecia: From Etiologies to Global Management
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events